Goldman Sachs’s Omega Protein OME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-40,118
| Closed | -$668K | – | 6904 |
|
|
2017
Q3 | $668K | Sell |
40,118
-8,541
| -18% | -$139K | ﹤0.01% | 4890 |
|
|
2017
Q2 | $871K | Sell |
48,659
-18,935
| -28% | -$354K | ﹤0.01% | 4593 |
|
|
2017
Q1 | $1.35M | Sell |
67,594
-2,914
| -4% | -$67.9K | ﹤0.01% | 4113 |
|
|
2016
Q4 | $1.77M | Sell |
70,508
-174,270
| -71% | -$4.12M | ﹤0.01% | 3965 |
|
|
2016
Q3 | $5.72M | Buy |
244,778
+201,677
| +468% | +$4.74M | ﹤0.01% | 2928 |
|
|
2016
Q2 | $862K | Sell |
43,101
-9,540
| -18% | -$178K | ﹤0.01% | 4331 |
|
|
2016
Q1 | $892K | Buy |
52,641
+20,940
| +66% | +$429K | ﹤0.01% | 4170 |
|
|
2015
Q4 | $704K | Sell |
31,701
-2,691
| -8% | -$56K | ﹤0.01% | 4626 |
|
|
2015
Q3 | $584K | Buy |
+34,392
| New | +$535K | ﹤0.01% | 4989 |
|
|
2015
Q2 | – | Sell |
-15,887
| Closed | -$217K | – | 7568 |
|
|
2015
Q1 | $217K | Sell |
15,887
-7,605
| -32% | -$87.8K | ﹤0.01% | 5951 |
|
|
2014
Q4 | $248K | Buy |
23,492
+5,857
| +33% | +$69.3K | ﹤0.01% | 5971 |
|
|
2014
Q3 | $220K | Sell |
17,635
-18,239
| -51% | -$254K | ﹤0.01% | 6073 |
|
|
2014
Q2 | $491K | Sell |
35,874
-29,111
| -45% | -$381K | ﹤0.01% | 5339 |
|
|
2014
Q1 | $784K | Sell |
64,985
-1,501
| -2% | -$17.2K | ﹤0.01% | 4901 |
|
|
2013
Q4 | $817K | Buy |
+66,486
| New | +$780K | ﹤0.01% | 4915 |
|
|
2013
Q3 | – | Sell |
-14,976
| Closed | -$134K | – | 6794 |
|
|
2013
Q2 | $134K | Buy |
+14,976
| New | +$151K | ﹤0.01% | 5777 |
|
Goldman Sachs's OME Position: Q4 2017 in Review
Goldman Sachs sold out of Omega Protein (OME) in Q4 2017, closing a stake of 40,118 shares — an estimated $668K sold.
Goldman Sachs first reported a position in OME in Q2 2013 and held it in 16 quarters. The position peaked at $5.72M in Q3 2016. 0 funds tracked by Wall St. Rank hold OME as of Q4 2017.
- Goldman Sachs reported no remaining Omega Protein position as of Q4 2017 after selling out during the quarter.
- Goldman Sachs sold 40,118 Omega Protein shares in Q4 2017, an estimated $668K.
- Goldman Sachs first reported a position in Omega Protein in Q2 2013 and held it in 16 quarters.
- Goldman Sachs's Omega Protein position peaked at $5.72M in Q3 2016.
- 0 funds tracked by Wall St. Rank held Omega Protein as of Q4 2017.
Based on Goldman Sachs's 13F filing for Q4 2017, filed 14 Feb 2018.